Amazon’s Acquisition of One Medical Being Investigated by FTC

Amazon’s Acquisitions Under FTC Review

The Federal Trade Commission (FTC) is currently scrutinizing Amazon’s acquisitions of iRobot and One Medical, which are valued at $1.7 billion and $3.9 billion respectively. These deals have the potential to disrupt their respective markets.

FTC Investigation and Potential Delays

1Life Healthcare, the parent company of One Medical, revealed that the FTC is looking into its merger with Amazon. The Commission has also started evaluating Amazon’s purchase of iRobot. The detailed inquiries from the FTC indicate that a formal investigation is likely, causing both companies to brace for a potentially lengthy and challenging process. Potential delays of up to a year and the possibility of lawsuits loom over Amazon’s finalization of the deals, as seen in previous cases like NVIDIA’s blocked acquisition of ARM due to competition concerns.